tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Ratios

300 Followers

Neuphoria Therapeutics Ratios

NEUP's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, NEUP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 14.31 3.56 3.45 4.87 12.46
Quick Ratio
 14.31 3.56 3.45 4.87 12.46
Cash Ratio
 12.85 3.37 3.29 4.42 10.00
Solvency Ratio
 -4.95 0.04 -2.19 -4.42 -3.77
Operating Cash Flow Ratio
 39.29 12.04 -3.83 -5.40 -6.48
Short-Term Operating Cash Flow Coverage
 1.74K 1.55K -443.27 -100.57 0.00
Net Current Asset Value
$ 16.27M$ 8.29M$ 3.04M$ 4.13M$ 22.99M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.02 0.02 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.02 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.18 1.50 1.58 1.32 1.15
Debt Service Coverage Ratio
 -655.55 6.96 -670.31 -214.25 -1.18K
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -1.55K
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 0.00
Interest Debt Per Share
 <0.01 0.14 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.85 175.27 0.55 0.36 0.81
Profitability Margins
Gross Profit Margin
101.58%100.00%0.00%0.00%0.00%
EBIT Margin
225.51%-7.21%0.00%0.00%-10506.50%
EBITDA Margin
217.07%-0.78%0.00%0.00%-10085.68%
Operating Profit Margin
250.04%-7.21%0.00%0.00%-10292.00%
Pretax Profit Margin
265.94%-5.35%0.00%0.00%-10523.25%
Net Profit Margin
263.11%-2.36%0.00%0.00%-8253.62%
Continuous Operations Profit Margin
263.11%-2.36%0.00%0.00%-8253.62%
Net Income Per EBT
98.94%44.11%99.44%97.44%78.43%
EBT Per EBIT
106.36%74.22%87.07%99.82%102.25%
Return on Assets (ROA)
-79.16%-0.85%-83.88%-111.62%-51.05%
Return on Equity (ROE)
-109.66%-1.28%-132.61%-147.75%-58.58%
Return on Capital Employed (ROCE)
-78.65%-3.05%-112.45%-126.66%-67.11%
Return on Invested Capital (ROIC)
-77.73%-1.34%-111.10%-122.74%-52.50%
Return on Tangible Assets
-127.22%-1.61%-171.92%-227.24%-78.26%
Earnings Yield
-95.89%-3.21%-1.87%-0.45%-0.24%
Efficiency Ratios
Receivables Turnover
 -6.52 0.00 0.00 0.00 0.06
Payables Turnover
 0.26 0.00 0.44 0.70 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 97.74 0.00 0.00 0.60
Asset Turnover
 -0.30 0.36 0.00 0.00 <0.01
Working Capital Turnover Ratio
 -0.51 1.21 0.00 0.00 0.01
Cash Conversion Cycle
 -1.44K 0.00 -825.20 -520.83 6.13K
Days of Sales Outstanding
 -55.95 0.00 0.00 0.00 6.13K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 1.38K 0.00 825.20 520.83 0.00
Operating Cycle
 -55.95 0.00 0.00 0.00 6.13K
Cash Flow Ratios
Operating Cash Flow Per Share
 10.99 47.59 -0.10 -0.08 -0.13
Free Cash Flow Per Share
 10.99 47.59 -0.10 -0.08 -0.13
CapEx Per Share
 <0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 19.82M 0.00 0.00 -39.43M -14.09K
Capital Expenditure Coverage Ratio
 19.82M 0.00 0.00 -39.43M -14.09K
Operating Cash Flow Coverage Ratio
 1.74K 340.99 -53.83 -38.23 -31.37
Operating Cash Flow to Sales Ratio
 -5.68 4.93 0.00 0.00 -53.85
Free Cash Flow Yield
207.21%670.23%-1.18%-0.20%-0.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.04 -31.17 -53.48 -224.01 -412.44
Price-to-Sales (P/S) Ratio
 -2.74 0.74 0.00 0.00 34.04K
Price-to-Book (P/B) Ratio
 0.98 0.40 70.92 330.97 241.63
Price-to-Free Cash Flow (P/FCF) Ratio
 0.48 0.15 -84.49 -492.49 -632.06
Price-to-Operating Cash Flow Ratio
 0.48 0.15 -84.49 -492.49 -632.10
Price-to-Earnings Growth (PEG) Ratio
 -0.02 -0.24 1.30 -7.28 -13.75
Price-to-Fair Value
 0.98 0.40 70.92 330.97 241.63
Enterprise Value Multiple
 -0.41 80.75 -54.99 -224.71 -336.72
Enterprise Value
 9.29M -9.84M 1.23B 4.84B 9.44B
EV to EBITDA
 -0.41 80.75 -54.99 -224.71 -336.72
EV to Sales
 -0.89 -0.63 0.00 0.00 33.96K
EV to Free Cash Flow
 0.16 -0.13 -83.65 -491.70 -630.55
EV to Operating Cash Flow
 0.16 -0.13 -83.65 -491.70 -630.59
Tangible Book Value Per Share
 3.01 5.20 0.02 0.04 0.21
Shareholders’ Equity Per Share
 5.44 17.79 0.12 0.12 0.35
Tax and Other Ratios
Effective Tax Rate
 0.01 0.56 <0.01 0.03 0.22
Revenue Per Share
 -1.94 9.64 0.00 0.00 <0.01
Net Income Per Share
 -5.09 -0.23 -0.15 -0.18 -0.20
Tax Burden
 0.99 0.44 0.99 0.97 0.78
Interest Burden
 1.18 0.74 1.00 1.00 1.00
Research & Development to Revenue
 -0.64 0.58 0.00 0.00 60.69
SG&A to Revenue
 -0.69 0.50 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 -15.65 10.47 0.00 0.00 7.00
Income Quality
 -0.15 -0.21 0.95 0.68 1.00
Currency in USD